Science Explorer Interactive view Map
Company · Seongnam-si · South Korea

Genome and Company (South Korea)

genomecom.co.krROR OpenAlex
Research works
100
▲ 507% vs 2013–17
Citations
973
9.7 per fractional work
Top-10% rate
15.3%
record average 16.5%
Open access
56%
world 28%

Not ranked overall: Genome and Company (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.44× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.92× its world share, 18 worksBiochemistry, Geneti…Immunology and Microbiology: 4.64× its world share, 3 worksImmunology and Micro…Neuroscience: 1.74× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.77× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.55× its world share, 0 worksChemistryComputer Science: 0.22× its world share, 1 worksComputer ScienceEnergy: 0.31× its world share, 0 worksEnergyEngineering: 0.11× its world share, 1 worksEngineeringEnvironmental Science: 0.23× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.51× its world share, 1 worksMaterials ScienceHealth Professions: 0.11× its world share, 0 worksHealth ProfessionsMedicine: 2.50× its world share, 28 worksMedicineNursing: 1.49× its world share, 0 worksNursingSocial Sciences: 0.14× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.9×. Every wedge is a field page.

Which keywords describe research at Genome and Company (South Korea)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cell-Free DNA, Targeted Therapy, Somatic Mutations, Cancer Genomics, Mutational Signatures, Cancer, Tumor Microenvironment and Inflammation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cell-Free DNA6▲ 108×2 topics
  2. Targeted Therapy5▲ 41×3 topics
  3. Inflammation5▲ 4.1×23 topics
  4. Cancer5▲ 6.0×22 topics
  5. Somatic Mutations4▲ 94×2 topics
  6. Cancer Genomics4▲ 105×1 topic
  7. Mutational Signatures4▲ 105×1 topic
  8. Tumor Microenvironment4▲ 16×6 topics
  9. Immunotherapy3▲ 7.1×7 topics
  10. Cancer Therapy3▲ 8.4×6 topics
  11. Prenatal Diagnosis2▲ 28×2 topics
  12. Angiogenesis2▲ 11×5 topics
  13. Chemotherapy2▲ 5.3×8 topics
  14. Oxidative Stress2▲ 2.2×14 topics
  15. Immune Checkpoint Blockade2▲ 32×1 topic
  16. Inflammatory Diseases2▲ 19×5 topics
  17. PD-1 and PD-L12▲ 32×1 topic
  18. Genomic Sequencing2▲ 27×2 topics
  19. Aneuploidy Screening2▲ 118×1 topic
  20. Maternal Plasma DNA Sequencing2▲ 118×1 topic
  21. Precision Medicine2▲ 6.2×6 topics
  22. Tumor Targeting2▲ 16×2 topics
  23. Cancer Risk2▲ 12×4 topics
  24. Immune Responses2▲ 20×2 topics
  25. Microbial Communities2▲ 6.5×3 topics
  26. Clinical Trials2▲ 3.8×7 topics
  27. Metabolism2▲ 5.0×8 topics
  28. Neurodegeneration2▲ 8.6×6 topics
  29. Gene Expression1▲ 4.0×6 topics
  30. Gut Microbiota1▲ 6.8×2 topics
  31. Metagenomic Analysis1▲ 19×1 topic
  32. Short-Chain Fatty Acids1▲ 19×1 topic
  33. Breast Cancer1▲ 8.4×4 topics
  34. PET Imaging1▲ 12×3 topics
  35. Genetic Testing1▲ 16×3 topics
  36. Glycosylation1▲ 17×2 topics
  37. Stromal Cells1▲ 24×2 topics
  38. Transcriptional Regulation1▲ 12×7 topics
  39. Epigenetic Regulation1▲ 8.2×3 topics
  40. Fc Receptors1▲ 32×1 topic

Which research topics does Genome and Company (South Korea) publish most on?

By volume in 2022–2025: Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Prenatal Screening and Diagnostics and Gut microbiota and health.

Cancer Genomics and Diag…4Cancer Genomics and Diagnostics: 4 fractional worksCancer Immunotherapy and…2Cancer Immunotherapy and Biomarkers: 2 fractional worksPrenatal Screening and D…2Prenatal Screening and Diagnostics: 2 fractional worksGut microbiota and health: 1 fractional worksPeptidase Inhibition and Analysis: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksAdvanced Computing and Algorithms: 1 fractional worksNanoparticle-Based Drug Delivery: 1 fractional worksThyroid and Parathyroid Surgery: 1 fractional worksGlioma Diagnosis and Treatment: 1 fractional works
Cancer ResearchOncologyPediatrics, Perinatology and Child HealthMolecular Biology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Genomics and Diagnostics Cancer Research 4 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 2 works
  3. 3 Prenatal Screening and Diagnostics Pediatrics, Perinatology and Child Health 2 works
  4. 4 Gut microbiota and health Molecular Biology 1 works
  5. 5 Peptidase Inhibition and Analysis Oncology 1 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  7. 7 Advanced Computing and Algorithms Urban Studies 1 works
  8. 8 Nanoparticle-Based Drug Delivery Biomaterials 1 works
  9. 9 Thyroid and Parathyroid Surgery Surgery 1 works
  10. 10 Glioma Diagnosis and Treatment Genetics 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available55.6%not open44.4%

World: 28% of research is openly available.

with international co-authors13.4%domestic only86.6%

World: 19% is written across borders.

How has Genome and Company (South Korea)'s research output changed?

Output in 2018–2022 was 507% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Seongnam-si

All research institutions in Seongnam-si

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.